OncoMatch/Clinical Trials/NCT06119867
CompariSon Between the EuroPeAn and Japanese pathologiCal InvEstigation for Colon Cancer (SPACE)
Is NCT06119867 recruiting? Yes, currently enrolling (May 2026). This Phase 3 trial studies non-drug interventions for colonic neoplasms.
In general, the European pathological examination method primarily relies on pathologists and does not require the involvement of surgeons. The Japanese pathological evaluation approach, on the other hand, involves the intervention of surgeons, particularly in the extraction of lymph nodes from fresh specimens and the assessment of specimen quality. Given that the Japanese pathological assessment method lacks systematic evaluation and there is currently no literature clearly demonstrating its diagnostic accuracy, the main objective of this study is to verify whether the diagnostic accuracy of the Japanese pathological investigation method is inferior to that of the European pathological evaluation method.
Check if I qualifyExtracted eligibility criteria
Prior therapy
Must have received: colectomy
Patients diagnosed with colon cancer who underwent colectomy
Cannot have received: colectomy
Patients diagnosed with colon cancer but did not undergo colectomy
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify